Boston Partners’s Cerence CRNC Stock Holding History

Boston Partners’s Portfolio CRNC Stock Details CRNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-46,726	Closed	-$720K	–	667
2020 Q1	$720K	Sell	46,726 -16,334	-26%	-$343K	﹤0.01%	559
2019 Q4	$1.34M	Buy	+63,060	New	+$1.03M	﹤0.01%	561

Other funds holding CRNC

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Isomer Partners New York $74.3M AUM 23.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Boston Partners's CRNC Position: Q2 2020 in Review

Boston Partners sold out of Cerence (CRNC) in Q2 2020, closing a stake of 46,726 shares — an estimated $720K sold.

Boston Partners first reported a position in CRNC in Q4 2019 and held it in 2 quarters. The position peaked at $1.34M in Q4 2019. 241 funds tracked by Wall St. Rank hold CRNC as of Q2 2020.

Boston Partners reported no remaining Cerence position as of Q2 2020 after selling out during the quarter.
Boston Partners sold 46,726 Cerence shares in Q2 2020, an estimated $720K.
Boston Partners first reported a position in Cerence in Q4 2019 and held it in 2 quarters.
Boston Partners's Cerence position peaked at $1.34M in Q4 2019.
241 funds tracked by Wall St. Rank held Cerence as of Q2 2020.

Based on Boston Partners's 13F filing for Q2 2020, filed 12 Aug 2020.